end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrentAndNoncurrent,AccountsReceivableGross,AccountsReceivableNet,AccountsReceivableNetCurrent,AccretionExpense,AccruedLiabilitiesCurrent,AccruedMarketingCostsCurrent,AccruedProfessionalFeesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllowanceForDoubtfulAccountsReceivable,AmortizationOfFinancingCosts,AmortizationOfFinancingCostsAndDiscounts,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightOutstanding,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ContractWithCustomerRefundLiabilityCurrent,CostOfGoodsAndServicesSold,DebtCurrent,DebtInstrumentCarryingAmount,DeferredFinanceCostsNet,DeferredIncomeTaxExpenseBenefit,DepositsAssetsCurrent,DepreciationDepletionAndAmortization,DerivativeFairValueOfDerivativeLiability,DerivativeGainLossOnDerivativeNet,DerivativeLiabilities,DueToRelatedPartiesCurrent,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EmployeeRelatedLiabilitiesCurrent,FiniteLivedIntangibleAssetsAccumulatedAmortization,FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths,FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear,FiniteLivedIntangibleAssetsAmortizationExpenseYearThree,FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo,FiniteLivedIntangibleAssetsNet,GrossProfit,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInInventories,IncreaseDecreaseInOtherCurrentLiabilities,IncreaseDecreaseInOtherNoncurrentLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncrementalCommonSharesAttributableToConversionOfPreferredStock,IntangibleAssetsNetExcludingGoodwill,InterestExpenseDebt,InterestExpenseDebtExcludingAmortization,InterestExpenseRelatedParty,InterestPaidNet,InterestPayableCurrent,InventoryFinishedGoods,InventoryFinishedGoodsNetOfReserves,InventoryGross,InventoryNet,InventoryNoncurrent,InventoryRawMaterials,InventoryRawMaterialsNetOfReserves,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebtCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccruedLiabilitiesCurrent,OtherAssets,OtherAssetsCurrent,OtherAssetsNoncurrent,OtherLiabilities,OtherLiabilitiesCurrent,OtherLiabilitiesNoncurrent,OtherPrepaidExpenseCurrent,PaidInKindInterest,PaymentsOfDebtIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssets,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,ProceedsFromRelatedPartyDebt,ProfitLoss,PropertyPlantAndEquipmentNet,ProvisionForDoubtfulAccounts,RepaymentsOfDebt,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,SellingGeneralAndAdministrativeExpense,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage,StockholdersEquity,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueShareBasedCompensationGross,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfSharesOutstandingBasic
2020-12-31,2021-03-31,10-K,"Petros Pharmaceuticals, Inc.",PTPI,CIK0001815903,USD,5609556.0,6560291.0,5152969.0,5152969.0,,14683786.0,,,79170225.0,,228800.0,,,,69854014.0,25905053.0,17139694.0,17139694.0,,4407962.0,0.0001,150000000.0,9707655.0,9707655.0,971.0,7100000.0,,7175029.0,6653292.0,12500.0,,4576.0,,9900000.0,,9890000.0,0.0,,,,519609.0,-6650218.0,,,,,32160919.0,,,,,,,,,,,,32160919.0,,,,,65885.0,434598.0,935866.0,760530.0,760530.0,11144257.0,325932.0,2872977.0,,,,,,,,52384962.0,69854014.0,41894042.0,7175029.0,,,,,,,,,639568.0,108971.0,530597.0,,579535.0,0.126,178381.0,579535.0,114784.0,579535.0,600920.0,221766.0,600920.0,391552.0,,,,0.0001,50000000.0,500.0,500.0,2847284.0,2847284.0,149452.0,,,64250.0,,,,-61702144.0,,,,,,,,,574331.0,51.43,,,17469052.0,,,0.0,,
2021-03-31,2021-05-14,10-Q,"Petros Pharmaceuticals, Inc.",PTPI,CIK0001815903,USD,5276283.0,7252380.0,6194198.0,6194198.0,,15382284.0,,69916.0,79615223.0,347207.0,231784.0,12500.0,12500.0,5195182.0,66154008.0,23963664.0,14566710.0,14566710.0,-2572984.0,4407962.0,0.0001,150000000.0,9798261.0,9798261.0,980.0,7000000.0,643386.0,5061264.0,5061264.0,,,4576.0,1728829.0,4500000.0,,4510000.0,0.0,,0.31,,186679.0,-1726273.0,6191740.0,5141498.0,4650787.0,5445729.0,30434646.0,3432220.0,3009081.0,,-333273.0,1044213.0,698498.0,-193987.0,74992.0,-100408.0,-172051.0,1600.0,30434646.0,173412.0,160912.0,,176677.0,50119.0,262079.0,941545.0,560864.0,560864.0,11144257.0,298785.0,2872977.0,834085.0,187739.0,,155242.0,189374.0,138297.0,220521.0,45230868.0,66154008.0,40220356.0,5061264.0,-2126403.0,,-446581.0,3009081.0,5629727.0,-2197507.0,44812.0,25156.0,613564.0,113052.0,500512.0,45942.0,554379.0,0.126,618479.0,,97083.0,554379.0,500512.0,296620.0,,473080.0,,,,0.0001,50000000.0,0.0,0.0,2637316.0,2637316.0,180819.0,,3009081.0,57062.0,2984.0,1592028.0,19181.0,-58693063.0,4075606.0,3881717.0,347207.0,1078346.0,288346.0,682166.0,43.89,215669.0,790000.0,38.41,3.74,,20923140.0,97800.0,,0.0,9754686.0,9753086.0
2021-06-30,2021-08-16,10-Q,"Petros Pharmaceuticals, Inc.",PTPI,CIK0001815903,USD,2597891.0,3292674.0,2020915.0,2020915.0,,13764857.0,,23479.0,80295724.0,450502.0,246541.0,,,5621263.0,56670244.0,16234052.0,11031177.0,11031177.0,,4407962.0,0.0001,150000000.0,9826599.0,9826599.0,983.0,5700000.0,393294.0,3425378.0,3425378.0,,,,1728828.0,2200000.0,,2220000.0,0.0,,-0.22,,75436.0,-3452547.0,6191740.0,3415225.0,4650787.0,5445729.0,28708372.0,2064355.0,-2106217.0,6700.0,,,,,,,,0.0,28708372.0,115525.0,115525.0,,,32825.0,178075.0,546668.0,439232.0,439232.0,11144257.0,261157.0,2872977.0,788143.0,187739.0,81107.0,155242.0,189374.0,92355.0,201316.0,37179517.0,56670244.0,34489946.0,3425378.0,,,,-2112917.0,6345047.0,-4280692.0,44812.0,,586827.0,117256.0,469571.0,45942.0,529056.0,0.126,398504.0,,136360.0,529056.0,469571.0,497915.0,,789794.0,,,,0.0001,50000000.0,0.0,0.0,2742728.0,2742728.0,188209.0,,,54507.0,,,500046.0,-60805980.0,2457649.0,4116173.0,,1213301.0,0.0,852166.0,34.25,,1213301.0,26.57,,,19490727.0,90002.0,,0.0,9802309.0,9802309.0
2021-09-30,2021-11-15,10-Q,"Petros Pharmaceuticals, Inc.",PTPI,CIK0001815903,USD,5312344.0,2929064.0,1952421.0,1952421.0,,11594114.0,1258255.0,31463.0,80348891.0,53167.0,303753.0,,,5621263.0,52035328.0,13354324.0,8135184.0,8135184.0,,4407962.0,0.0001,150000000.0,9826599.0,9826599.0,983.0,3200000.0,319158.0,1740752.0,1740752.0,,,,1728829.0,300000.0,1970000.0,250000.0,0.0,-0.17,,-0.17,25417.0,-5178821.0,6191740.0,1688951.0,4650787.0,5445729.0,26982098.0,1826011.0,-1694553.0,2345.0,,,,,,,,,26982098.0,67936.0,67936.0,,,16681.0,189923.0,435927.0,518481.0,518481.0,11144257.0,328558.0,2872977.0,742201.0,187739.0,81107.0,155242.0,189374.0,46413.0,182863.0,34188332.0,52035328.0,33500583.0,1740752.0,,,,-1696898.0,5422628.0,-3596617.0,44812.0,,559338.0,121589.0,437749.0,45942.0,502697.0,0.126,225514.0,502697.0,612673.0,,,649468.0,437749.0,587319.0,,,,0.0001,50000000.0,0.0,0.0,2748238.0,2748238.0,172205.0,,,51952.0,,,280576.0,-62502878.0,2145169.0,3413223.0,,1213301.0,0.0,852166.0,35.77,,1213301.0,26.57,,,17846996.0,,,0.0,9826599.0,9826599.0
